Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Smidt
The Role of Magnetic Resonance Imaging in Assessing Residual Disease and Pathologic Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: A Systematic Review
Insights into Imaging
Nuclear Medicine
Radiology
Imaging
Developing a Patient Decision Aid for the Treatment of Women With Early Stage Breast Cancer: The Struggle Between Simplicity and Complexity
BMC Medical Informatics and Decision Making
Health Policy
Health Informatics
Related publications
Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy Is Associated With Molecular Biomarker Profile
Clinical Breast Cancer
Cancer Research
Oncology
Magnetic Resonance Imaging After Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate Between No Residual Carcinoma and Residual Ductal Carcinoma in Situ in Patients With Triple-Negative Breast Cancer
PLoS ONE
Multidisciplinary
Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy
Radiology
Nuclear Medicine
Radiology
Imaging
P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Neoadjuvant Chemotherapy: Role in Breast Cancer
Genome-Wide DNA Methylation Signatures to Predict Pathologic Complete Response From Combined Neoadjuvant Chemotherapy With Bevacizumab in Breast Cancer
PLoS ONE
Multidisciplinary
Accuracy of Ultrasonography and Mammography in Predicting Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
American Journal of Surgery
Medicine
Surgery
